Related Experiment Video

Updated: Jun 9, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

327

Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer

Ru-Yi Chen1, Li-Jian Ding2, Yan-Jun Liu1

  • 1State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo 315211, China.

Marine Drugs
|October 25, 2024
PubMed

Insights

Compound 4, a marine-derived alkaloid, effectively combats triple-negative breast cancer (TNBC) by inhibiting cell migration and inducing cell death. It also targets MAP3K11, offering potential for new TNBC therapies.

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Triple-negative breast cancer (TNBC) presents significant challenges due to high mortality and drug resistance.
  • Currently, no targeted therapies are available for TNBC.
  • Marine natural products offer a promising source for novel anti-cancer agents.

Purpose of the Study:

  • To evaluate the anti-cancer activity of compound 4, a staurosporine alkaloid from marine sponge-derived Streptomyces sp. NBU3142.
  • To investigate the effects of compound 4 on MDA-MB-231 cells and their paclitaxel-resistant variants.
  • To identify the molecular target of compound 4 in breast cancer cells.

Main Methods:

  • Cell culture of MDA-MB-231 and paclitaxel-resistant MDA-MB-231 cells.
  • Assessment of cell migration, apoptosis, cell cycle, and senescence.
  • Identification of the molecular target using biochemical and cellular assays.

Main Results:

  • Compound 4 demonstrated potent anti-TNBC activity, inhibiting cell migration.
  • It effectively induced apoptosis and cell cycle arrest in both sensitive and resistant cell lines.
  • Compound 4 was identified to target MAP3K11, a key kinase in breast cancer progression.

Conclusions:

  • Compound 4 exhibits significant potential as a therapeutic agent against triple-negative breast cancer.
  • Targeting MAP3K11 with compound 4 offers a novel strategy for overcoming TNBC drug resistance.
  • Further research into compound 4 and its mechanism is warranted for clinical development.
Keywords:
MAP3K11apoptosiscancer stem cellscell migrationstaurosporine analoguetriple-negative breast cancer

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.7K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K